{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-013848","form_type":"8-K","ticker":"OPK","cik":"0000944809","company_name":"OPKO HEALTH, INC.","filed_at":"2025-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.901483+00:00","generated_at":"2026-05-23T03:16:22.418491+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"OPKO Health Q1 revenue down 14% to $149.9M; net loss narrows to $67.6M; signs $225M Labcorp asset sale","bullets":["Revenue $149.9M vs $173.7M YoY; net loss $0.10 per share vs $0.12 per share.","Signed definitive agreement to sell oncology testing assets to Labcorp for up to $225M ($192.5M at close + $32.5M earnout); expected close H2 2025.","Board authorized additional $100M for stock buyback (total $200M); ~$40.2M repurchased under prior program since July 2024.","Post-quarter: exchanged $159.2M convertible notes for 121.4M shares + $63.5M cash.","Collaboration with Entera Bio for oral GLP-1/glucagon tablet; OPKO purchased 3.7M Entera shares at $2.17/share."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-013848","json":"https://secwatch.observer/filing/0001437749-25-013848.json","markdown":"https://secwatch.observer/filing/0001437749-25-013848.md","text":"https://secwatch.observer/filing/0001437749-25-013848.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/944809/000143774925013848/0001437749-25-013848-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/944809/000143774925013848/opk20250417_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T03:16:22.418491+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}